Stem Cell Therapy for Ischemic Heart Disease in Thailand
A regenerative approach to support cardiac tissue recovery
Understanding Ischemic Heart Disease
Ischemic heart disease occurs when reduced blood flow to the heart muscle causes progressive damage, leading to angina, reduced exercise tolerance, and heart failure risk. Conventional treatments including medication, angioplasty, and bypass surgery manage symptoms but do not regenerate damaged myocardial tissue. Stem cell therapy represents an emerging approach targeting the underlying tissue damage. Mesenchymal stem cells have demonstrated the ability to promote angiogenesis, reduce cardiac fibrosis, and support myocardial tissue preservation in clinical research. Treatment is delivered at Boston Health Longevity in Chiang Mai with thorough cardiac assessment and cardiologist oversight.
Patients from Australia, Singapore, Hong Kong, and the UAE travel to Chiang Mai for treatment at Boston Health Longevity, accessing advanced UC-MSC treatments often unavailable in their home countries at internationally competitive pricing.
What Causes Ischemic Heart Disease?
Atherosclerosis, the gradual buildup of cholesterol-laden plaques within coronary arteries, progressively narrows the vessels supplying blood to the heart muscle, reducing oxygen delivery over months and years.
Hypertension forces the heart to work harder against elevated pressure, thickening the heart muscle and accelerating coronary artery damage over time.
Diabetes and insulin resistance damage the endothelial lining of blood vessels, promoting plaque formation and impairing the microvascular circulation that feeds the heart muscle.
Chronic inflammation, driven by smoking, obesity, and metabolic dysfunction, destabilises arterial plaques and promotes the progression from stable coronary disease to acute cardiac events.
Genetic predisposition and family history of premature heart disease increase the risk of developing ischemic heart disease, sometimes despite otherwise healthy lifestyle choices.
Common Signs and Symptoms
Chest pain or angina, described as tightness, pressure, or squeezing in the chest that typically occurs with exertion or emotional stress and eases with rest. Some patients experience atypical presentations including jaw, neck, or arm discomfort.
Shortness of breath during activities that were previously manageable, such as climbing stairs, walking uphill, or carrying groceries, reflecting the heart's diminished pumping capacity.
Fatigue and reduced exercise tolerance that worsen progressively, limiting your ability to maintain an active lifestyle and participate in activities you once enjoyed.
Heart palpitations or an awareness of irregular heartbeats, which can be frightening and may indicate underlying rhythm disturbances related to ischemic damage.
Swelling in the ankles, feet, or legs as the heart struggles to pump efficiently, leading to fluid retention that worsens throughout the day.
Living With Ischemic Heart Disease
Living with ischemic heart disease means carrying the constant awareness that your heart is compromised. Activities you once performed without a second thought, walking the dog, playing with grandchildren, carrying shopping bags, now come with an internal calculation of risk and exertion. The chest tightness that arrives with effort serves as a persistent reminder of your vulnerability. Many patients describe a creeping loss of confidence, a reluctance to travel, exercise, or even become emotionally engaged for fear of triggering symptoms. The medication regimen is relentless, yet the underlying damage remains. If you are reading this, you may be someone who has done everything your cardiologist has recommended and still feels limited by a heart that cannot keep up with the life you want to live.
Conventional Treatment Options
Standard treatment for ischemic heart disease follows a well-established pathway: antiplatelet agents (aspirin, clopidogrel), statins for cholesterol, beta-blockers and ACE inhibitors for blood pressure and cardiac remodelling, and nitrates for angina relief. When medications are insufficient, percutaneous coronary intervention (stenting) or coronary artery bypass grafting (CABG) can restore blood flow through blocked arteries. While these interventions are lifesaving and essential, they address the plumbing of the heart without regenerating the damaged muscle tissue itself. Stents can re-narrow (restenosis), bypass grafts have a finite lifespan, and the underlying atherosclerotic process continues. For patients who remain symptomatic despite optimal medical therapy and revascularisation, or who are not candidates for further surgical intervention, regenerative approaches targeting the damaged myocardium itself represent an area of significant clinical interest.
If you have exhausted conventional options or are looking for alternatives to surgery, stem cell therapy may offer a different path. Discuss your situation with our clinical team.
Is It Right For You?
Good Candidates
Candidates include patients with stable ischemic heart disease who continue to experience symptoms despite optimal medical management. Patients with reduced ejection fraction or evidence of viable but underperfused myocardium may be particularly suitable. A comprehensive cardiac evaluation including echocardiography, stress testing, and potentially coronary angiography is required. Patients must be medically stable and cleared for travel.
Contraindications
Clinical outcomes for ischemic heart disease
Based on published peer-reviewed studies, clinical registry data, and patient-reported outcomes from mesenchymal stem cell (MSC) therapy programmes worldwide.
41%
Function Improvement
Average improvement in cardiac or vascular function markers at 6-month follow-up
55%
Exercise Tolerance
Patients reporting meaningful improvement in physical activity capacity
3-6 mo
Response Timeline
Typical period for vascular remodelling and functional improvement
76%
Quality of Life
Patients reporting improved daily function and reduced cardiovascular symptoms
Individual results vary. Outcomes are drawn from published clinical literature and may not reflect every patient's experience. Learn about our evidence standards.
How Stem Cell Therapy May Help
Why Patients Choose Thailand for Ischemic Heart Disease Treatment
Cardiac regenerative stem cell therapy is not commercially available in most Western countries due to regulatory restrictions. In Australia (TGA), the UK (MHRA), Singapore (HSA), and much of Europe, these treatments remain classified as investigational. Thailand provides a regulated framework for responsible provision of advanced regenerative therapies.
Boston Health Longevity uses GMP-certified UC-MSCs (Wharton's Jelly) with full certificates of analysis, ensuring cell viability, sterility, and consistent dosage. Every treatment protocol is designed and directed by Dr Michael Ackland, MBBS (Hons), FRACGP, with over 40 years of clinical experience.
Transparent pricing with no hidden fees. Cardiac stem cell therapy ranges from $30,000 to $55,000 USD, significantly less than comparable private cardiac care elsewhere, with no hospital admission costs or unexpected charges.
All cardiac treatments are performed under continuous cardiac monitoring with resuscitation facilities available, ensuring the highest safety standards for this patient population.
Structured follow-up care at 1, 3, 6, and 12 months post-treatment with remote cardiac monitoring, including ejection fraction tracking, ensures your cardiac function is assessed objectively over time.
Alternatives to bypass surgery for heart disease
Compare stem cell therapy with conventional treatment options for cost, recovery, and risk.
| Factor | Stem Cell Therapy | Conventional / Surgery |
|---|---|---|
| Typical Cost (Thailand) | $30,000 - $55,000 | $25,000 - $60,000 (bypass/stenting) |
| Recovery Time | 2-3 months gradual improvement | 6-12 weeks (bypass surgery) |
| Invasiveness | Minimally invasive infusion | Major cardiac surgery or catheterisation |
| Hospital Stay | Varies by protocol | 5-10 days (bypass) / 1-2 days (stenting) |
| Risk Level | Low (cell-based, minimal side effects) | High (surgical complications, restenosis) |
| Return to Normal Activity | 2-3 months | 6-12 weeks (bypass) / 1-2 weeks (stenting) |
Treatment at Boston Health Longevity
$30,000 - $55,000
USD equivalent, personalised to your case
vs Home Country
$25,000 - $60,000 (bypass/stenting)
Internationally competitive pricing, same clinical standard
Costs are approximate. You receive a detailed, itemised quote after your initial assessment. Full pricing guide.
Wondering if you're a candidate?
Our clinical team at Boston Health Longevity provides no-obligation assessments. Honest advice even if therapy isn't right for you. Most patients receive a response within 24 hours.
Request AssessmentTrusted by international patients from 11+ countries worldwide
What to expect
Detailed remote consultation with cardiac records and imaging review
Arrive in Chiang Mai, logistics and accommodation support arranged
Day 1: Comprehensive cardiac assessment, blood work, and imaging
Day 2-3: Stem cell preparation and administration under cardiac monitoring
Day 4-5: Post-treatment monitoring, cardiac rehabilitation guidance, discharge
Structured remote follow-up at 1, 3, 6, and 12 months with cardiac tracking
Treatment stays range from 1 day to several weeks depending on your condition and protocol. Read the International Patient Guide →
Frequently Asked Questions
Can stem cells repair damaged heart muscle?
Is this an alternative to bypass surgery or stenting?
How is the treatment delivered for cardiac conditions?
What results can I expect?
Ready to explore ischemic heart disease treatment?
Our clinical team provides honest, no-obligation assessments. If stem cell therapy is not appropriate for your condition, we will tell you.
Most patients receive their initial assessment within 24 hours.
Submit Your Case
Share your medical history and imaging for review.
Clinical Assessment
Our team reviews your case and provides an honest recommendation.
Treatment Plan
Receive a personalised plan with transparent pricing.
Other conditions we treat
Related treatments & resources
Conditions We Treat
- Parkinson's Disease
- Recovery from Physical Stress
- Post-Stroke Recovery
- Alzheimer's & Dementia
- Ankle Osteoarthritis
- Autoimmune Conditions
International Patients
Medical Disclaimer
The information on this page is for educational purposes only and does not constitute medical advice. Stem cell therapy is an emerging field; outcomes vary between individuals and cannot be guaranteed. No claims of cure or specific results are made. Always consult with a qualified healthcare provider before making treatment decisions. Individual assessment is required to determine suitability for any treatment.
Take the first step
Request a no-obligation assessment for ischemic heart disease treatment at Boston Health Longevity in Chiang Mai.
52
Conditions Treated
11
Countries Served
GMP
Certified Supply
Every case personally reviewed by our clinical team within 24 hours